Clinical Trial Update: Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating endomyocardial botulinum toxin injections in patients with persistent atrial fibrillation. No results are reported yet;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Persistent Atrial Fibrillation | Phase 2 | Status: UNKNOWN